Texas A&M Institute part of national effort to harness nuclear laser fusion for limitless energy
2023-12-08
Nuclear fusion, the process that powers the sun, is the ultimate source of energy for all life on Earth. On the sun, deuterium and tritium nuclei combine to produce an alpha particle (the nucleus of a helium atom) and a neutron. The dream is to do the same down here, on Earth, in a controlled manner.
It’s for good reason that harnessing fusion energy is one of the greatest scientific and technological challenges of the 21st century. Fusion requires the fuel to be heated to more than 100 million degrees (10 times hotter than the core of the sun). Practical fusion energy also requires that the burning fuel is kept at these hot temperatures long enough so that energy ...
How health system hesitancies contributed to COVID risks
2023-12-08
More than 1.2 million people have died in the United States during the COVID-19 pandemic to date, more documented deaths than any other nation on Earth.
While many have attributed the high death toll on widespread personal hesitancy to wear masks, avoid crowded places or receive vaccines once they were developed, there were several “system hesitancies” that contributed to the tragic outcomes that need addressing, according to an analysis published Dec. 6, 2023, in Health Affairs Forefront.
The analysis ...
Stand Up to Cancer names Julian Adams, Ph.D., President and CEO
2023-12-08
LOS ANGELES – December 8, 2023 – Stand Up To Cancer® (SU2C) today announced the appointment of Julian Adams, Ph.D., as president and chief executive officer, which will be effective on January 1, 2024. Adams had previously served on SU2C’s Scientific Advisory Committee since 2008, and officially joined SU2C in July 2023 in the newly created position of chief science officer. He succeeds Russell Chew, who joins SU2C’s Board of Directors.
Adams is a longtime oncology researcher and pharmaceutical industry senior executive specializing in drug discovery and development in cancer. With this appointment, Adams assumes management responsibility for SU2C’s overall ...
Immersive VR goggles for mice unlock new potential for brain science
2023-12-08
Northwestern University researchers have developed new virtual reality (VR) goggles for mice.
Besides just being cute, these miniature goggles provide more immersive experiences for mice living in laboratory settings. By more faithfully simulating natural environments, the researchers can more accurately and precisely study the neural circuitry that underlies behavior.
Compared to current state-of-the-art systems, which simply surround mice with computer or projection screens, the new goggles provide a leap in advancement. In current systems, mice can still see the lab environment peeking out from behind the screens, and the screens’ ...
Racial and ethnic differences in hospice use among Medicaid-only and dual-eligible decedents
2023-12-08
About The Study: In this study, in both Medicaid only and dual-eligible populations, Hispanic and non-Hispanic Black individuals had the lowest odds of receiving hospice, and Hispanic individuals had the highest odds of a short hospice stay. Knowledge about, access to, and acceptance of hospice may be lacking for these low-income individuals. Further research is needed to understand barriers to and facilitators of hospice use for people with nursing facility stays.
Authors: Julie ...
County–level variation in preterm birth rates
2023-12-08
About The Study: In this analysis of U.S. county-level preterm and early preterm birth rates, substantial geographic disparities were observed, which were associated with place-based social disadvantage. Stability in aggregated rates of preterm birth at the national level masked increases in nearly 1 in 6 counties between 2007 and 2019.
Authors: Sadiya S. Khan, M.D.,M.S., of the Northwestern University Feinberg School of Medicine in Chicago, is the corresponding author.
To access the embargoed study: Visit our For The Media website at ...
T cells tackle new 'Pirola' SARS-CoV-2 variant
2023-12-08
LA JOLLA, CA—In August, researchers detected a new SARS-CoV-2 "variant of concern" in patients in Israel and Denmark. Since then, this variant, dubbed BA.2.86 or "Pirola," has made its way around the globe. The Pirola variant has raised alarms because it is highly mutated. In fact, Pirola is as mutated as the Omicron variant was, compared with the early SARS-CoV-2 variant included in the original vaccinations.
As Pirola spreads, researchers at La Jolla Institute for Immunology (LJI) are investigating whether COVID-19 vaccines (or previous ...
MIT engineers design a robotic replica of the heart’s right chamber
2023-12-08
MIT engineers have developed a robotic replica of the heart’s right ventricle, which mimics the beating and blood-pumping action of live hearts.
The robo-ventricle combines real heart tissue with synthetic, balloon-like artificial muscles that enable scientists to control the ventricle’s contractions while observing how its natural valves and other intricate structures function.
The artificial ventricle can be tuned to mimic healthy and diseased states. The team manipulated the model to simulate conditions of right ventricular dysfunction, ...
New cause of diabetes discovered, offering potential target for new classes of drugs to treat the disease
2023-12-08
Dec. 8, 2023
Contact:
Bill Lubinger
216.368.4443
william.lubinger@case.edu
Ansley Kelm
678-313-6525
Ansley.Kelm@UHhospitals.org
CLEVELAND—Researchers at Case Western Reserve University and University Hospitals have identified an enzyme that blocks insulin produced in the body—a discovery that could provide a new target to treat diabetes.
Their study, published Dec. 5 in the journal Cell, focuses on nitric oxide, a compound that dilates blood vessels, improves memory, fights infection and stimulates the release of hormones, among ...
MD Anderson and Rigel Pharmaceuticals announce strategic alliance to advance olutasidenib in AML and other cancers
2023-12-08
HOUSTON and SOUTH SAN FRANCISCO, Calif. ― The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to expand the evaluation of olutasidenib in acute myeloid leukemia (AML) and other hematologic cancers.
The alliance brings together MD Anderson’s clinical research expertise with Rigel’s differentiated targeted molecule. Under the strategic collaboration, Rigel and MD Anderson will evaluate the potential of olutasidenib to treat newly diagnosed and relapsed ...
New insights into Zebra mussel attachment fibers offer potential solutions to combat invasive species, develop sustainable materials
2023-12-08
A recent study from researchers in Canada and Germany has revealed that an unlikely event, occurring over 12 million years ago played an important role in shaping one of Canada’s most damaging invasive species.
Zebra and quagga mussels, belonging to the Dreissenid family, are widespread freshwater invasive species throughout North America that present a significant danger to native ecosystems by competing for resources. Using a fibrous anchor called a byssus, Dreissenid mussels contribute to biofouling on surfaces and obstruct intake structures in power stations and water treatment plants.
“This new study, which looks into the way these mussels stick to surfaces, may help improve ...
A micro-ring resonator with big potential
2023-12-08
EPFL researchers have developed a hybrid device that significantly improves existing, ubiquitous laser technology.
The team at EPFL’s Photonic Systems Laboratory (PHOSL) has developed a chip-scale laser source that enhances the performance of semiconductor lasers while enabling the generation of shorter wavelengths. This pioneering work, led by Professor Camille Brès and postdoctoral researcher Marco Clementi from EPFL’s School of Engineering represents a significant advance in the field of photonics, with implications for telecommunications, metrology, and other high-precision applications.
The ...
Skipping adjuvant radiotherapy may not impact risk of recurrence or progression in patients with low-risk DCIS
2023-12-08
SAN ANTONIO – Patients with low-risk ductal carcinoma in situ (DCIS) who skipped adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to those with high-risk DCIS who received adjuvant radiotherapy, according to results from the E4112 clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.
“Nearly all women with DCIS—a noninvasive form of breast cancer—will have their cancer successfully removed, but some women will have a high risk of the disease returning or progressing to invasive breast cancer,” said Seema A. Khan, MD, a professor of surgery and the Bluhm Family ...
Some breast cancer survivors may safely de-escalate mammography three years after surgery
2023-12-08
Women 50 or older who de-escalated to less-frequent mammography three years after curative surgery for early-stage breast cancer had similar outcomes to women who received annual mammography, according to results from the Mammo-50 trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.
Both U.S. and U.K. guidelines recommend annual breast cancer screening following surgery to remove early-stage breast cancer; in the U.S., annual mammography is recommended indefinitely, and in the U.K., it is recommended for five years, followed by screening every three years for patients 50 years and older.
However, the optimal screening schedule has yet to ...
Potentially targetable fusion RNAs may be more common in metastatic breast cancer than previously realized
2023-12-08
SAN ANTONIO – Comprehensive profiling of fusion RNAs present in a large cohort of metastatic breast tumors revealed unique fusion mutations that may be therapeutically targetable, according to results presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.
Fusion mutations occur when a portion of one gene becomes fused to a portion of another, which can create gene products with new functions. They are common in cancer types that are characterized by genomic rearrangements and structural damage to the DNA, including breast cancer.
“Fusion RNAs may serve as ...
Study reveals insights into tacking diabetic kidney disease - with a side order of how anti-obesity drugs work
2023-12-08
Data from Australian researchers could partly explain why a trial of a new drug for diabetes, was recently halted because it was found to be so effective. Importantly, the data also reveals how anti-obesity drugs like Ozempic, actually work, which to date have been a mystery.
In early November the FLOW trial of the drug semaglutide on the progression of renal impairment in people with type 2 diabetes and chronic kidney disease was halted ahead of schedule because of the drug’s efficacy.
Part of the rationale for the cessation of the trial could be explained by ...
Study on battery recycling shows China is in 1st place
2023-12-08
With the increase in the production of batteries for electric vehicles, demand is also rising for the necessary raw materials. In view of risks to the supply chain, environmental problems and precarious working conditions which are all associated with the mining and transportation of these materials, the recycling of battery materials has become an important issue in research, politics and industry. Prof. Stephan von Delft from the University of Münster (Germany) heads a team of researchers from the fields of science ...
Veins of bacteria could form a self-healing system for concrete infrastructure
2023-12-08
In hopes of producing concrete structures that can repair their cracks, researchers from Drexel University’s College of Engineering are putting a new twist on an old trick for improving the durability of concrete. Fiber reinforcement has been around since the first masons were mixing horsehair into their mud. But the Drexel research team is taking this method to the next level by turning reinforcing fibers into a living tissue system that rushes concrete-healing bacteria to the site of cracks to repair the damage.
Recently reported in the journal Construction ...
First observation of structures resulting from 3D domain swapping in antibody light chains
2023-12-08
Ikoma, Japan – Antibodies (immunoglobulins) are Y-shaped proteins that recognize and neutralize specific pathogens. Their ability to target specific molecules or cells has made them promising candidates for future drug development. However, their light chains—parts of the antibody that contribute to recognizing and binding to specific antigens—misfold and aggregate, leading to amyloidosis, a condition that brings about complications and tissue dysfunction in the body. In the context of drug development, antibody aggregation can compromise their capacity to bind to antigens ...
Scholars say it's time to declare a new epoch on the moon, the 'lunar Anthropocene'
2023-12-08
LAWRENCE — Human beings first disturbed moon dust on Sept. 13, 1959, when the USSR’s unmanned spacecraft Luna 2 alighted on the lunar surface. In the following decades, more than a hundred other spacecraft have touched the moon — both crewed and uncrewed, sometimes landing and sometimes crashing. The most famous of these were NASA’s Apollo Lunar Modules, which transported humans to the moon’s surface to the astonishment of humankind.
In the coming years, missions and projects already planned will change the face of the moon ...
Researchers safely integrate fragile 2D materials into devices
2023-12-08
Two-dimensional materials, which are only a few atoms thick, can exhibit some incredible properties, such as the ability to carry electric charge extremely efficiently, which could boost the performance of next-generation electronic devices.
But integrating 2D materials into devices and systems like computer chips is notoriously difficult. These ultrathin structures can be damaged by conventional fabrication techniques, which often rely on the use of chemicals, high temperatures, or destructive processes like etching.
To overcome this challenge, researchers from MIT and elsewhere have developed a new technique to integrate 2D materials into devices in a single ...
Digital multi-sided platforms transform traditional value chains in business-to-business service sales
2023-12-08
Various digital platforms are becoming increasingly common in business-to-business (B2B) activities. They enable building competitiveness and boosting selling and buying. The platforms also offer different ways of building long-term customer relationships in B2B service sales. A recent study found that digital platforms are transforming traditional value chains based on linear value creation towards a platform-based, multi-sided, digital value network.
“The network is administered and orchestrated by the platform owner, who must attract a sufficient number ...
The first European manifesto for more sustainable museums
2023-12-08
Venice, Amsterdam, Paris, December 8, 2023 – Today, the Center for Cultural Heritage Technologies of the Italian Institute of Technology (CCHT-IIT), the University of Amsterdam/Rijksmuseum, and CNRS/École Normale Supérieure de Paris-Saclay launch the first manifesto for sustainable conservation of cultural heritage. The manifesto aims to improve conservation practices and promote more sustainable and ecological methods in museum practices.
During the COP28 in Dubai, the United Nations event on ...
Atlantic Ocean near Bermuda is warmer and more acidic than ever, 40 years of observation show
2023-12-08
Decade-long ocean warming which impacts ocean circulation, a decrease in oxygen levels that contributes to changes in salinification and nutrient supply, and ocean acidification are just some of the challenges the world’s oceans are facing.
In 1988, a comprehensive sustained ocean time-series of observations, called the Bermuda Atlantic Time-series Study (BATS), began at a site about 80 km southeast of the island of Bermuda. There, scientists take monthly samples of the physics, biology, and chemistry of the ocean’s surface and depths. In a new paper published in Frontiers in Marine Science, researchers have now presented the latest findings from ...
Battle of the AIs in medical research: ChatGPT vs Elicit
2023-12-08
Can AI save us from the arduous and time-consuming task of academic research collection? An international team of researchers investigated the credibility and efficiency of generative AI as an information-gathering tool in the medical field.
The research team, led by Professor Masaru Enomoto of the Graduate School of Medicine at Osaka Metropolitan University, fed identical clinical questions and literature selection criteria to two generative AIs; ChatGPT and Elicit. The results showed that while ChatGPT suggested fictitious articles, Elicit was efficient, suggesting multiple references within a few minutes with the same level of accuracy as the researchers.
“This ...
[1] ... [769]
[770]
[771]
[772]
[773]
[774]
[775]
[776]
777
[778]
[779]
[780]
[781]
[782]
[783]
[784]
[785]
... [8098]
Press-News.org - Free Press Release Distribution service.